SymbioCellTech
Business Services · Utah, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
615 S Arapeen Dr Ste 210, Salt Lake City...Phone Number
(801) 503-3990Website
www.symbiocelltech.comRevenue
<$5 MillionIndustry
About SymbioCellTech
SymbioCellTech is focused on developing innovative therapies for Type 1 Diabetes, aiming to eliminate the need for daily insulin injections and reduce complications associated with the disease. Their flagship product, Neo-Islets, offers a next-generation solution that does not rely on immuno-suppressive agents. The company targets individuals suffering from Type 1 Diabetes, particularly the 16 million people affected in the United States. Recognized for their advancements, they were awarded the American Diabetes Association's Innovation Challenge Award in 2024.Explore more
SymbioCellTech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to SymbioCellTech
Compare insights from companies similar to SymbioCellTech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SymbioCellTech Tech Stack
A closer look at the technologies used by SymbioCellTech
Top Business Services Companies
Frequently Asked Questions Regarding SymbioCellTech
Sign Up For FreeTo access detailed company insights
SymbioCellTech is focused on developing innovative therapies for Type 1 Diabetes, aiming to eliminate the need for daily insulin injections and reduce complications associated with the disease. Their flagship product, Neo-Islets, offers a next-generation solution that does not rely on immuno-suppressive agents. The company targets individuals suffe... Read More
